What is the usual intramuscular dose of haloperidol (Haldol) for severe agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intramuscular Haloperidol Dosing for Severe Agitation

For severe agitation in adults, the usual intramuscular dose of haloperidol is 5 mg, with a range of 2-5 mg for initial administration. 1

FDA-Approved Dosing

The FDA label for haloperidol IM explicitly states that parenteral medication in doses of 2 mg to 5 mg is utilized for prompt control of the acutely agitated schizophrenic patient with moderately severe to very severe symptoms 1. Subsequent doses may be given as often as every hour, though 4-8 hour intervals are typically satisfactory, with a maximum of 20 mg/day 1.

Evidence-Based Dosing Considerations

Standard Adult Dosing

Multiple clinical trials consistently used 5 mg IM haloperidol as the standard comparator dose for acute agitation 2, 3. This dose achieved adequate sedation in approximately 75% of patients with a single injection 4 and had a mean time to sedation of 28.3 minutes 2.

Geriatric Patients (≥65 years)

For older adults, significantly lower doses are warranted. The FDA label specifically notes that debilitated or geriatric patients require less haloperidol, with optimal response obtained through more gradual dosage adjustments at lower levels 1.

Recent evidence strongly supports this:

  • Low-dose haloperidol (≤0.5 mg) demonstrated similar efficacy to higher doses (>0.5 mg) in older adults with improved safety outcomes 5, 6
  • The 2025 geriatric emergency medicine guidelines emphasize that older adults require lower doses and greater tolerance of time-to-sedation to reduce adverse events 7
  • No patients receiving ≤0.5 mg required additional doses within 4 hours, compared to those receiving higher doses 6

Combination Therapy

Haloperidol 5 mg combined with lorazepam 2 mg is superior to either agent alone for rapid tranquilization 8. This combination:

  • Produces more rapid tranquilization (significant differences at 1-3 hours) 8
  • Requires fewer repeat doses 2
  • Is considered the treatment of choice for acute psychotic agitation by multiple studies 8

The alternative combination of haloperidol 10 mg with promethazine 25-50 mg also showed efficacy, producing more patients tranquil/asleep at earlier time points compared to lorazepam 4 mg alone 2.

Critical Safety Considerations

Dose-Response Relationship

The 2025 geriatric guidelines found increased risk of adverse events with escalating doses, recommending use of the lowest effective dose 7. Serious adverse events occurred in 16.8% of older adults receiving antipsychotics or anxiolytics 7.

Route of Administration

Intramuscular and intravenous use increased the risk for adverse drug events relative to oral administration 7. When possible, oral formulations should be considered first, particularly in older adults.

Common Pitfalls to Avoid

  • Do not use 10 mg as an initial dose in older adults - this significantly increases adverse event risk without improving efficacy 5, 6
  • Avoid repeated dosing more frequently than every 4 hours unless clinically necessary, as this increases cumulative adverse effects
  • Monitor for extrapyramidal symptoms (incidence ~6-7% at 7.5 mg doses) 4
  • Check for QTc prolongation, though haloperidol rarely exceeds 500 ms at therapeutic doses 2

Practical Dosing Algorithm

For adults <65 years with severe agitation:

  • Initial dose: 5 mg IM haloperidol
  • Consider adding lorazepam 2 mg IM for enhanced efficacy
  • May repeat every 4-8 hours as needed (maximum 20 mg/day)

For adults ≥65 years with severe agitation:

  • Initial dose: 0.5 mg IM haloperidol for mild-moderate agitation
  • May use up to 2 mg IM for severe agitation, but reserve higher doses only when absolutely necessary
  • Longer time-to-sedation should be tolerated to minimize adverse events 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.